Učitavanje...
An intestinal microbiota-farnesoid X receptor axis modulates metabolic disease
The gut microbiota is associated with metabolic diseases including obesity, insulin resistance and non-alcoholic fatty liver disease (NAFLD), as demonstrated by correlative studies and by transplant of microbiota from obese humans and mice into germ-free mice. Modification of the microbiota by treat...
Spremljeno u:
| Izdano u: | Gastroenterology |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5159222/ https://ncbi.nlm.nih.gov/pubmed/27639801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2016.08.057 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|